Tendency for Excessive Sleep Movement

BTBD9 and MEIS1 are the two variants most consistently associated with restless legs syndrome (RLS) and periodic limb movement during sleep, involuntary leg movements that fragment sleep architecture without necessarily fully waking the sleeper. Both genes are involved in dopamine signaling and iron handling in the central nervous system.

Carriers of common BTBD9 and MEIS1 variants are associated with significantly elevated risk for periodic limb movements and RLS symptoms, and the pattern compounds with low ferritin, since brain iron status directly influences dopamine availability in the relevant neural circuits. Even "normal" ferritin (15–50 ng/mL) is often inadequate in RLS-susceptible carriers; clinical practice often targets ferritin >75 in symptomatic carriers.

Iron status is the most actionable lever. Addressing low ferritin can substantially reduce symptoms in genetically susceptible carriers. Caffeine, alcohol, and certain medications (including some SSRIs, antihistamines, and dopamine antagonists) worsen symptoms. Magnesium supports some clients. Regular physical activity, especially evening stretching, reduces nighttime movement.

The bed partner who reports "you kick all night" or the morning-tired-despite-8-hours pattern often isn’t just light sleep. It’s involuntary movement under the surface. Which BTBD9/MEIS1 variant pattern you carry, combined with where ferritin actually sits, decides whether the right intervention is iron, dopamine support, or both.